- Home
- PRME vs NVTS Comparison
PRME vs NVTS Comparison
Compare PRME & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- NVTS
- Stock Information
- Founded
- PRME 2019
- NVTS 2014
- Country
- PRME United States
- NVTS United States
- Employees
- PRME N/A
- NVTS N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- NVTS Semiconductors
- Sector
- PRME Health Care
- NVTS Technology
- Exchange
- PRME Nasdaq
- NVTS Nasdaq
- Market Cap
- PRME 424.9M
- NVTS 473.3M
- IPO Year
- PRME 2022
- NVTS N/A
- Fundamental
- Price
- PRME $2.97
- NVTS $2.02
- Analyst Decision
- PRME Strong Buy
- NVTS Buy
- Analyst Count
- PRME 8
- NVTS 8
- Target Price
- PRME $13.86
- NVTS $4.75
- AVG Volume (30 Days)
- PRME 1.0M
- NVTS 3.2M
- Earning Date
- PRME 11-12-2024
- NVTS 11-04-2024
- Dividend Yield
- PRME N/A
- NVTS N/A
- EPS Growth
- PRME N/A
- NVTS N/A
- EPS
- PRME N/A
- NVTS N/A
- Revenue
- PRME $800,000.00
- NVTS $91,381,000.00
- Revenue This Year
- PRME N/A
- NVTS $8.34
- Revenue Next Year
- PRME $21.23
- NVTS $5.50
- P/E Ratio
- PRME N/A
- NVTS N/A
- Revenue Growth
- PRME N/A
- NVTS 38.99
- 52 Week Low
- PRME $2.85
- NVTS $1.75
- 52 Week High
- PRME $9.86
- NVTS $8.44
- Technical
- Relative Strength Index (RSI)
- PRME 30.86
- NVTS 43.21
- Support Level
- PRME $4.03
- NVTS $1.75
- Resistance Level
- PRME $4.49
- NVTS $1.88
- Average True Range (ATR)
- PRME 0.32
- NVTS 0.16
- MACD
- PRME -0.14
- NVTS -0.02
- Stochastic Oscillator
- PRME 6.45
- NVTS 28.72
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About NVTS Navitas Semiconductor Corporation
Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.